{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:43:47Z","timestamp":1790912627220,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ihj.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T20:15:20Z","timestamp":1473711320000},"page":"371-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease \u2013 Demystifying controversies"],"prefix":"10.1016","volume":"69","author":[{"given":"Kader","family":"Muneer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anishkumar","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ihj.2016.08.007_bib0125","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"issue":"7232","key":"10.1016\/j.ihj.2016.08.007_bib0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/bmj.320.7232.428","article-title":"Management: diuretics, ACE inhibitors, and nitrates","volume":"320","author":"Davies","year":"2000","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ihj.2016.08.007_bib0135","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency","volume":"63","author":"Damman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.08.007_bib0140","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1038\/sj.ki.5001919","article-title":"The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: a European perspective","volume":"70","author":"Khalifeh","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ihj.2016.08.007_bib0145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"June","key":"10.1016\/j.ihj.2016.08.007_bib0150","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ihj.2016.08.007_bib0155","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2008.12.007","article-title":"Heart failure with normal left ventricular ejection fraction","volume":"53","author":"Maeder","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2016.08.007_bib0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000435838","article-title":"Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment","volume":"5","author":"Di Lullo","year":"2015","journal-title":"Cardioren Med"},{"issue":"9","key":"10.1016\/j.ihj.2016.08.007_bib0165","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ihj.2016.08.007_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/eurheartj\/eht436","article-title":"Non-pharmacological modulation of the autonomic tone to treat heart failure","volume":"35","author":"Singh","year":"2013","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.ihj.2016.08.007_bib0175","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ihj.2016.08.007_bib0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ihj.2016.08.007_bib0185","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/hc4101.096153","article-title":"Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council for high blood pressure research of the American Heart Association","volume":"104","author":"Schoolwerth","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ihj.2016.08.007_bib0190","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/hrt.2003.019505","article-title":"Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death","volume":"91","author":"Main","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2016.08.007_bib0195","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.08.007_bib0200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ihj.2016.08.007_bib0205","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"ONTARGET Investigators","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ihj.2016.08.007_bib0210","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"issue":"9386","key":"10.1016\/j.ihj.2016.08.007_bib0215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.08.007_bib0220","series-title":"The Cardiorenal Syndrome","author":"Heywood","year":"2012"},{"issue":"9","key":"10.1016\/j.ihj.2016.08.007_bib0225","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data","volume":"63","author":"Damman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.08.007_bib0230","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.1016\/j.ihj.2016.08.007_bib0235","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ihj.2016.08.007_bib0240","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1525-139X.2009.00697.x","article-title":"Antihypertensive agents in hemodialysis patients: a current perspective","volume":"23","author":"Inrig","year":"2010","journal-title":"Semin Dial"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216303765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216303765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T10:23:55Z","timestamp":1536402235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483216303765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0019483216303765"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2016.08.007","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease \u2013 Demystifying controversies","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}